Vietnamnet.vn
Podcast
biosimilar drugs
Update news biosimilar drugs
Novartis aims to nearly triple biosimilar drugs on market by 2020
Switzerland's Novartis pledged to nearly triple its number of biosimilar drugs on the market by 2020, raising its bet that cheaper versions of blockbuster cancer and immune system medicines will snatch billions in rivals' profits.
Hunting growth, Samsung races to get up to speed on biosimilar drugs
As Samsung Bioepis raced to be first to market with a copy of Enbrel, a blockbuster rheumatoid arthritis drug, countdown clocks reminded workers - heading for lunch, meetings or even the washroom - of the days to the first mass production run.
